Clinical Trials in San Francisco

Showing 8821-8840 of 12,991 trials

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

NCT02398461

This is a Phase 1, multi-center, double-blind, randomized, placebo-controlled, dose-escalation study in subjects with relapsing Multiple Sclerosis (MS). The primary outcome will be the safety and tolerability of a single dose of rHIgM22 in relapsing MS subjects.

Multiple Sclerosis, Acute Relapsing

Acorda Therapeutics27 participantsStarted Apr 2015

Long Beach, California, United States • Sacramento, California, United States • San Francisco, California, United States +9 more locations

COMPLETEDPhase 2< 1 mile

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

NCT00058123

RATIONALE: Biological therapies such as poly-ICLC use different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This phase II trial is studying how poly-ICLC works in treating patients with recurrent, progressive, or relapsed anaplastic glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins55 participantsStarted Mar 2003

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +5 more locations

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Find Trials by Condition in San Francisco

Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study

SF1126 for Patients With Relapsed or Refractory Neuroblastoma

Transfusion Requirements in Cardiac Surgery III

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Caring Letters for Military Suicide Prevention

Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment

Localized Therapeutics for the Treatment of Gastrointestinal Disorders

Imatinib in Systemic Sclerosis

12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Automated Screen for Fetal Aneuploidy